SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001415889-15-001722
Filing Date
2015-05-14
Accepted
2015-05-14 16:50:46
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q fpmi10q_mar312015.htm 10-Q 524376
2 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARB ex31-1.htm EX-31.1 16624
3 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARB ex31-2.htm EX-31.2 16706
4 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO U.S.C. SECTION 1350 AS ex32-1.htm EX-32.1 5696
5 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO U.S.C. SECTION 1350 AS ex32-2.htm EX-32.2 5861
  Complete submission text file 0001415889-15-001722.txt   3188045

Data Files

Seq Description Document Type Size
6 fpmi-20150331.xml EX-101.INS 333127
7 fpmi-20150331.xsd EX-101.SCH 27233
8 fpmi-20150331_cal.xml EX-101.CAL 36083
9 fpmi-20150331_def.xml EX-101.DEF 118868
10 fpmi-20150331_lab.xml EX-101.LAB 205912
11 fpmi-20150331_pre.xml EX-101.PRE 169871
Mailing Address 8 HILLSIDE AVENUE SUITE 207 MONTCLAIR NJ 07042
Business Address 8 HILLSIDE AVENUE SUITE 207 MONTCLAIR NJ 07042 973-744-1565
FLUOROPHARMA MEDICAL, INC. (Filer) CIK: 0001402785 (see all company filings)

IRS No.: 208325616 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-147193 | Film No.: 15863647
SIC: 2835 In Vitro & In Vivo Diagnostic Substances